Augmenting antidepressants Flashcards
Algorithm for treatment resistant depression (TRD)
Lack of response to current antidepressant
CONSIDER
-Pseudo TRD
—-thyroid, nonadherance, latent bipolar
TRUE TRD
-No improvement at all or intolerable AE
—-switch to another in the same class
-Partial and unsatisying improvement
—-augmentation strategies like other antidepressant, lithium, atypical or combo with psychotherapy
-nonresponse to 2 or 3 adequate antidepressant trials
—-neurostimulation, antidepressants with innovative MOA
adjunctive medication options
atpyicals
antidepressants
lithium
T3
stimulants
atypicals with meta analysis and with RCT
meta analyses
-aripiprazole
-olanzapine
—–+fluoxetine: mixed results vs monotherapy
-quetiapine
-risperidone
RCT
-Brexpiprazole
-ziprasidone
overall worse tolerability than placebo
antidepressant adjuncts
-poss efficacy for mirtazapine
- no difference for combos
► Bupropion + escitalopram vs. either alone
► Escitalopram + bupropion SR vs. escitalopram
► Mirtazapine + venlafaxine vs. escitalopram
adjunctive use of antidepressants is assoc with inc AE compared to monotherapy
Lithium as adjunct
effective though small trials
Lithium +TCA
Lithium + SSRI
- 3 trials and 74 patients
Triiodothyronine (T3)
2 RCT
better tolerated than lithium
stimulants as adjunct
modafanil
- marginal evidence/mixed results
Lisdexamfetamine
- partial response
-other trials neg
- other stimulant trials neg
Tx for depression after unsatisfactory response to SSRI according to AHRQ
Insufficient evidence to eval benefits of
-dose change
-SSRI switch
-Non SSRI antidep switch
-Non andidepressant switch
-Nonpharm tx switch
-Ongoing monotherapy with SSRI as opposed to adjunctive antidepressant
Comparable result when switch to another antidep or adding non antidep to the initial SSRI
Adding atypical antipsych to SSRI is assoc with higher response and remission rates vs placebo
Insuff evidence for other augmentation strategies
strongest evidence for adjunctive rx
better than placebo
aripiprazole
quetiapine
better than placebo
- Lithium
-T3